摘要 |
Compounds having the Formula (I), including pharmaceutically acceptable salts thereof, [INSERT CHEMICAL STRUCTURE HERE] (I), wherein at least one of X1, X2 or X3 is {INSERT CHEMICAL STRUCTURE HERE] (i), and any remaining X1, X2 or X3 is hydrogen, which are useful as kinase inhibitors, wherein R1, R2, R3, R4, R5, R6, A1, A2and m are as described herein. ® KIPO & WIPO 2009
|